223 related articles for article (PubMed ID: 9058729)
1. Mantle cell lymphoma: a clinicopathologic study of 80 cases.
Argatoff LH; Connors JM; Klasa RJ; Horsman DE; Gascoyne RD
Blood; 1997 Mar; 89(6):2067-78. PubMed ID: 9058729
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma. Morphologic findings in bone marrow involvement.
Wasman J; Rosenthal NS; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):196-200. PubMed ID: 8712173
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic and clinical study on 126 cases of B cell non-Hodgkin's lymphoma with bone marrow involvement].
An G; Zhang JW; Shi LH; Yi SH; Zhao YZ; Qi JY; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):34-7. PubMed ID: 21429399
[TBL] [Abstract][Full Text] [Related]
5. Blastic transformation of mantle cell lymphoma.
Kaleem Z; Wakoff AR; Smith RP; Hess JL
Arch Pathol Lab Med; 1996 Jun; 120(6):577-80. PubMed ID: 8651861
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
7. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: a retrospective study of 121 cases.
Samaha H; Dumontet C; Ketterer N; Moullet I; Thieblemont C; Bouafia F; Callet-Bauchu E; Felman P; Berger F; Salles G; Coiffier B
Leukemia; 1998 Aug; 12(8):1281-7. PubMed ID: 9697885
[TBL] [Abstract][Full Text] [Related]
9. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma.
Kurtin PJ
Adv Anat Pathol; 1998 Nov; 5(6):376-98. PubMed ID: 10095879
[TBL] [Abstract][Full Text] [Related]
11. Mantle zone lymphoma. A clinicopathologic study of 22 cases.
Duggan MJ; Weisenburger DD; Ye YL; Bast MA; Pierson JL; Linder J; Armitage JO
Cancer; 1990 Aug; 66(3):522-9. PubMed ID: 2364363
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system involvement in patients with mantle cell lymphoma.
Oinonen R; Franssila K; Elonen E
Ann Hematol; 1999 Mar; 78(3):145-9. PubMed ID: 10211757
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
[No Abstract] [Full Text] [Related]
14. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.
Weisenburger DD; Vose JM; Greiner TC; Lynch JC; Chan WC; Bierman PJ; Dave BJ; Sanger WG; Armitage JO
Am J Hematol; 2000 Jul; 64(3):190-6. PubMed ID: 10861815
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases.
Au WY; Horsman DE; Gascoyne RD; Viswanatha DS; Klasa RJ; Connors JM
Leuk Lymphoma; 2004 Mar; 45(3):519-28. PubMed ID: 15160914
[TBL] [Abstract][Full Text] [Related]
17. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
18. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis.
Segal GH; Masih AS; Fox AC; Jorgensen T; Scott M; Braylan RC
Blood; 1995 Mar; 85(6):1570-9. PubMed ID: 7534138
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
Majlis A; Pugh WC; Rodriguez MA; Benedict WF; Cabanillas F
J Clin Oncol; 1997 Apr; 15(4):1664-71. PubMed ID: 9193367
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.
Bosch F; López-Guillermo A; Campo E; Ribera JM; Conde E; Piris MA; Vallespí T; Woessner S; Montserrat E
Cancer; 1998 Feb; 82(3):567-75. PubMed ID: 9452276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
